{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T06:13:21Z","timestamp":1793945601316,"version":"4.8.0"},"reference-count":41,"publisher":"Informa UK Limited","issue":"7","license":[{"start":{"date-parts":[[2024,5,2]],"date-time":"2024-05-02T00:00:00Z","timestamp":1714608000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Merck & Co., Inc"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Leukemia &amp; Lymphoma"],"published-print":{"date-parts":[[2024,6,6]]},"DOI":"10.1080\/10428194.2024.2331631","type":"journal-article","created":{"date-parts":[[2024,5,2]],"date-time":"2024-05-02T16:07:40Z","timestamp":1714666060000},"page":"932-942","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":12,"title":["Real-world patterns and sequences of targeted therapy use in chronic lymphocytic leukemia and small lymphocytic lymphoma in the United States: a longitudinal study"],"prefix":"10.1080","volume":"65","author":[{"given":"Scott F.","family":"Huntington","sequence":"first","affiliation":[{"name":"Yale School of Medicine","place":["New Haven, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy Y.","family":"Cheng","sequence":"additional","affiliation":[{"name":"Analysis Group, Inc","place":["Boston, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric M.","family":"Sarpong","sequence":"additional","affiliation":[{"name":"Merck & Co., Inc","place":["Rahway, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyang","family":"Leng","sequence":"additional","affiliation":[{"name":"Merck & Co., Inc","place":["Rahway, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed Z. H.","family":"Farooqui","sequence":"additional","affiliation":[{"name":"Merck & Co., Inc","place":["Rahway, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uchechukwu Samuel","family":"Agu","sequence":"additional","affiliation":[{"name":"University of Arizona","place":["Tucson, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryaline","family":"Catillon","sequence":"additional","affiliation":[{"name":"Analysis Group, Inc","place":["Boston, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Lejeune","sequence":"additional","affiliation":[{"name":"Groupe d\u2019analyse","place":["Lt\u00e9e, Montr\u00e9al, Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathaniel","family":"Downes","sequence":"additional","affiliation":[{"name":"Analysis Group, Inc","place":["Boston, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Matay","sequence":"additional","affiliation":[{"name":"Analysis Group, Inc","place":["Boston, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei Sheng","family":"Duh","sequence":"additional","affiliation":[{"name":"Analysis Group, Inc","place":["Boston, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico","family":"De Nigris","sequence":"additional","affiliation":[{"name":"MSD (UK) Limited","place":["London, UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2024,5,2]]},"reference":[{"key":"e_1_3_7_2_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00428-022-03460-y"},{"key":"e_1_3_7_3_1","unstructured":"National Cancer Institute. SEER Cancer Stat Facts: chronic lymphocyticleukemia\/small lymphocytic lymphoma Bethesda MD. 2023 [cited 2023 July 31]. Available from: https:\/\/seer.cancer.gov\/statfacts\/html\/cllsll.html"},{"key":"e_1_3_7_4_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2019.236000"},{"key":"e_1_3_7_5_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.26367"},{"key":"e_1_3_7_6_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-09-806398"},{"key":"e_1_3_7_7_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-021-01054-w"},{"key":"#cr-split#-e_1_3_7_8_1.1","unstructured":"US Food and Drug Administration (FDA). FDA approves zanubrutinib for chronic lymphocytic leukemiaor small lymphocytic lymphoma 2023 [updated 2023 January 19"},{"key":"#cr-split#-e_1_3_7_8_1.2","unstructured":"cited 2023 July 31]. Available from: https:\/\/www.fda. gov\/drugs\/resources-information-approved-drugs\/ fda-approves-zanubrutinib-chronic-lymphocytic-leukemia-or-small-lymphocytic-lymphoma#:\u223c:text=FDA%20approves%20zanubrutinib%20for%20chronic% 20lymphocytic%20leukemia%20or%20small%20lymphocytic%20lymphoma -Share&text=On%20January%2019%2C%202023%2C%20 the small%20lymphocytic%20lympho ma%20(SLL)"},{"key":"e_1_3_7_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(20)30443-5"},{"key":"e_1_3_7_10_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1509388"},{"key":"e_1_3_7_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30262-2"},{"key":"e_1_3_7_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(22)00293-5"},{"key":"e_1_3_7_13_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-21-1237"},{"key":"e_1_3_7_14_1","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2023.2190436"},{"key":"e_1_3_7_15_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-020-01350-w"},{"key":"e_1_3_7_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clml.2019.10.009"},{"key":"e_1_3_7_17_1","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2014-0059"},{"key":"e_1_3_7_18_1","doi-asserted-by":"publisher","DOI":"10.2217\/lmt.15.12"},{"key":"e_1_3_7_19_1","doi-asserted-by":"publisher","DOI":"10.18553\/jmcp.2013.19.6.461"},{"key":"e_1_3_7_20_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0196007"},{"key":"e_1_3_7_21_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1713976"},{"key":"e_1_3_7_22_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2022008068"},{"key":"#cr-split#-e_1_3_7_23_1.1","unstructured":"US Food and Drug Administration (FDA). FDA approves venetoclax for CLL or SLL with or without 17 p deletion after one prior therapy 2018 [updated 2018 June 8"},{"key":"#cr-split#-e_1_3_7_23_1.2","unstructured":"cited 2023 September 12]. Available from: https:\/\/www.fda.gov\/drugs\/resources-information-approved-drugs\/fda-approves-venetoclax-cll-or-sll-or-without-17-p-deletion-after-one-prior-therapy#:\u223c:text=On%20June%208%2C%202018%2C%20the at%20least%20one%20prior%20therapy"},{"key":"#cr-split#-e_1_3_7_24_1.1","unstructured":"US Food and Drug Administration (FDA). Project Orbis: FDA approves acalabrutinib for CLL and SLL 2019 [updated 2019 November 21"},{"key":"#cr-split#-e_1_3_7_24_1.2","unstructured":"cited 2023 September 12]. Available from: https:\/\/www.fda.gov\/drugs\/resources-information-approved-drugs\/project-orbis-fda-approves-acalabrutinib-cll-and-sll"},{"key":"e_1_3_7_25_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.26683"},{"key":"e_1_3_7_26_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-020-00870-w"},{"key":"e_1_3_7_27_1","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.720704"},{"key":"e_1_3_7_28_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-11-846808"},{"key":"e_1_3_7_29_1","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.2998"},{"key":"e_1_3_7_30_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2016.147900"},{"key":"e_1_3_7_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clml.2018.10.005"},{"key":"e_1_3_7_32_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2022-168081"},{"key":"e_1_3_7_33_1","doi-asserted-by":"publisher","DOI":"10.1186\/1752-1947-2-275"},{"key":"e_1_3_7_34_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-017-0612-x"},{"key":"e_1_3_7_35_1","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9124034"},{"key":"e_1_3_7_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clml.2022.09.007"},{"key":"e_1_3_7_37_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2020004782"},{"key":"e_1_3_7_38_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdx031"},{"key":"e_1_3_7_39_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-19-3815"}],"container-title":["Leukemia &amp; Lymphoma"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/10428194.2024.2331631","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,12]],"date-time":"2026-04-12T13:31:04Z","timestamp":1776000664000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/10428194.2024.2331631"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,2]]},"references-count":41,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,6,6]]}},"alternative-id":["10.1080\/10428194.2024.2331631"],"URL":"https:\/\/doi.org\/10.1080\/10428194.2024.2331631","relation":{},"ISSN":["1042-8194","1029-2403"],"issn-type":[{"value":"1042-8194","type":"print"},{"value":"1029-2403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,2]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ilal20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ilal20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2024-01-29","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-03-04","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-03-12","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-05-02","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}